Easterly Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Easterly Investment Partners's AMGN Position: Q1 2026 in Review
Easterly Investment Partners sold out of Amgen (AMGN) in Q1 2026, closing a stake of 45,448 shares — an estimated $14.9M sold.
Easterly Investment Partners first reported a position in AMGN in Q3 2021 and held it in 18 quarters. The position peaked at $17.4M in Q2 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Easterly Investment Partners reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Easterly Investment Partners sold 45,448 Amgen shares in Q1 2026, an estimated $14.9M.
- Easterly Investment Partners first reported a position in Amgen in Q3 2021 and held it in 18 quarters.
- Easterly Investment Partners's Amgen position peaked at $17.4M in Q2 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Easterly Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.